What you actually need to know about PCD CareHub.

PCD CareHub is a Dutch buy-and-build operator for healthcare technology. We start with what suppliers have to demonstrate today: NIS2 (the Dutch Cyberbeveiligingswet) and NEN 7510. Next we connect suppliers through CareConnect, and over time we build the bridge to the European Health Data Space (EHDS). We build a FHIR-first integration layer, retain founders via long-term ownership and share a common compliance foundation — GDPR-by-design operationally, EHDS-ready via FHIR R4 and NEN 7510 in preparation (target Q1 2027). Not a software company, not traditional PE — we are an operator with capital.

The CareHub ecosystem is the set of healthcare software companies that PCD CareHub connects through buy-and-build. Open, interoperable and human-centric: EHRs, ECDs, scheduling, CRM, telemonitoring and client portals talking to each other via FHIR and HL7 standards. Not a rip-and-replace platform — the layers around existing systems.

Three reasons that are concretely verifiable: (1) Compliance for healthtech suppliers as the starting point, with the EHDS bridge as the long-term direction, not generic 'healthcare investment', (2) FHIR-first technical approach instead of company-by-company integration, (3) Founder retention as a governance choice, not a marketing claim. We build for 5–10 years, not for an exit.

Three audiences: (1) Care organisations that want to reduce administrative burden through smart integration; (2) Healthtech companies that want to grow inside an open ecosystem; (3) Investors looking for long-term value via buy-and-build in European healthtech. Each audience has its own page with a specific proposition.

Three differences: (1) Horizon: 5–10 years of building instead of 3–5 year exit-driven cycles; (2) Founder retention: founders and clinical teams stay onboard with substantial equity, no full buy-out; (3) Integration discipline: we add a shared FHIR layer and compliance layer rather than letting portfolio companies operate in isolation.

Operationally: founders retain control over product and clinical decisions; PCD CareHub provides capital, governance discipline and shared infrastructure. Financially: substantial rollover or pre-money equity instead of earn-outs. Culturally: no integration shock — companies keep their identity inside the ecosystem.

Three steps: (1) Connect — existing EHR/ECD, scheduling and portal data is linked via open standards (FHIR, HL7, Nictiz zibs); (2) Automate — routine tasks are picked up by AI assistants with human oversight; (3) Scale — once integration is live, the organisation can grow without proportional manual work. Typical lead time 6–12 months.

Our current cases sit in chain care (hospital + care partners), mental healthcare (client journeys + admin-burden reduction) and hybrid care (24/7 availability with workflow automation). More broadly: healthtech that fits the CareHub ecosystem and where founder retention is a good fit.

No — both certifications are in preparation, targeting Q1 2027. We operate according to the principles of NEN 7510 and ISO 27001 and have shaped the architecture accordingly, but we claim no formal certificate until it has been issued. We are GDPR-compliant (processing registers, DPIAs, DPAs with Supabase/Vercel/Resend). Wegiz-ready for electronic data exchange. EHDS-ready in implementation.

Mapping to both FHIR R4 (the current Dutch zib standard) and R5 (the newer version with EHDS conformance). We support Nictiz zibs, SNOMED CT and LOINC. For each portfolio company we document which FHIR profiles and conformance statements apply.

Data stays with the care provider; PCD CareHub does not centrally process patient data. The integration layer runs per company, in EU regions with DPAs under GDPR. For EHDS we implement machine-readable consent via the FHIR Patient.consent resource. Audit trails are inspection-ready and meet NEN 7510 and EHDS article 12 verifiability requirements.

30 minutes, no commitment. We listen first to your situation (organisation, current systems, goal). Then we share our observation and — if there is a fit — a concrete proposal for next steps. No sales pitch, no NDA pressure upfront. For portfolio companies a second session follows with more technical depth.

Six members: Frans van den Berg (CEO, MSc Biomedical Sciences + Corporate MBA, Lead Pharma CEO, BIO-Europe speaker), Niels Roest (Chairman & Chief AI Innovation Officer, former Defence/Police), Patrick Dinkela (COO & Vice-Chairman, co-founder), Coby Dinkela (Chief Communication Officer, co-founder), Frank van Antwerpen (CFO, RA), Kevin de Rooij (Legal Director, Master Law & Economics). Full profiles on /leiderschap.

Plan a conversation via /contact or email info@pcdcarehub.com directly. For investments and deal flow we work after a personal introduction and — where appropriate — under NDA. For general questions, partnership proposals or media enquiries an email suffices.